Rationality Of Analgesic-Antipyretic Use In Dengue Hemorrhagic Fever Patients

Indah Sri Hartini; Eko Yudha Prasetyo; Dyah Ayu Kusumaratni; Arshy Prodyanatasari

Authors

Indah Sri Hartini Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Indonesia
Eko Yudha Prasetyo Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Indonesia
Dyah Ayu Kusumaratni Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Indonesia
Arshy Prodyanatasari Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Indonesia

Keywords:

Dengue Haemoragic Fever, analgesic antipyretic, rationality

Abstract

Dengue haemorrhagic fever (DHF) is a disease caused by acute dengue virus infection transmitted through the bite of the Aedes Aegepty mosquito. Data from the health department states that the increase in the Case Fatality Rate (CFR) of DHF in 2020 is 0.8% and in 2021 is 1.1% while the national target is <1%. DHF patients need proper treatment to minimize the occurrence of contraindications in patients. DHF patients generally experience initial symptoms of sudden high fever >38oC, headache or pain behind the eyeball, muscle and bone pain. Treatment of DHF patients to reduce the pain experienced is by giving the right antipyretic analgesic. Based on this, the researcher wants to examine the description of the use of analgesic-antipyretics to determine the rationality level of the use of analgesic-antipyretics in DHF patients. The rationality of analgesic-antipyretic use measured, including patient accuracy, drug accuracy, indication accuracy, and dose accuracy. The type of research conducted was non-experimental observational research with retrospective data collection and the sampling technique used was totality sampling. Data collection was carried out based on patient medical record data in the period January-August 2022. In accordance with WHO guidelines and the National Guidelines for Health Services for Dengue management, the provision of analgesic-antipyretic drugs in accordance with the drug of choice is paracetamol. Based on the data obtained, there were 74 DHF patients with 57% female patients and 43 male patients, and 42% of patients were children. The rationality of analgesic-antipyretic use in DHF patients is known to be 100% right patient; 37.84 right drug; 100% right indication; and 98.65% right dose.

Author Biography

Dyah Ayu Kusumaratni, Institut Ilmu Kesehatan Bhakti Wiyata Kediri, Indonesia

Dosen Farmasi, Institut Ilmu Kesehatan Bhakti Wiyata Kediri

References

Mardhatilah, S., Ambiar, R. I., & Erlyn, P. (2020). Picturean Kejadian Demam Berdarah Dengue (Dbd) Di Wilayah Kerja Puskesmas Dempo Kota Palembang. MESINA (Medical Scientific Journal), 1, 23-32.

Kemenkes,R.I. (2016). Kementerian Kesehatan Republik Indonesia. Indonesia: Ditjen Gizi dan Kia.

Wirantika, W. R., & Susilowati, Y. (2020). Pengaruh Pendidikan Kesehatan terhadap Pengetahuan dan Perilaku Siswa dengan Persebaran Demam Berdarah Dengue (DBD) Di Sekolah. Jurnal Health Sains, 1(6), 427-431.

Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., ... & Campbell, P. J. (2013). Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood, The Journal of the American Society of Hematology, 122(22), 3616-3627.

Butarbutar, R. N., Sumampouw, O. J., & Pinontoan, O. R. (2019). Trend Kejadian Demam Berdarah Dengue Di Kota Manado Tahun 2009-2018. KESMAS: Jurnal Kesehatan Masyarakat Universitas Sam Ratulangi, 8(6).

Nasriah, N. (2019). Faktor yang berhubungan dengan kejadian dbd di Pulau Balang Lompo Kabupaten Pangkep. Sulolipu: Media Komunikasi Sivitas Akademika dan Masyarakat, 17(2), 73-81.

Yudhastuti, R., & Lusno, M. F. D. (2020). Picturean Kasus Demam Berdarah Dengue (DBD) Di Pulau Bali Tahun 2012-2017. Jurnal Kesehatan Lingkungan Indonesia, 19(1), 27-34.

Herawati, A., Febrianti, D., Santoso, D., Putra, F. B. A., Sitorus, G. G., & Tasya, R. A. (2022). Analisis Pencegahan Demam Berdarah Dengue (DBD). Journal of Public Health Education, 1(4), 221-228.

Ginanjar, G. (2008). Demam berdarah. PT Mizan Publika.

Ningsih, T. A., & Assagaff, F. (2023). Modul Penanggulangan DBD oleh Tim Jumantik SD.

Ilham, S. P. I. (2023). Profil Penderita Demam Berdarah Dengue Di Rawat Inap Di Rsud Nene Mallomo Kabupaten Sidrap Tahun 2021 (Doctoral dissertation, Universitas Hasanuddin).

Jatim, D. (2021). Profil Kesehatan Dinas Kesehatan Provinsi Jawa Timur 2021. Dinas Kesehatan Provinsi Jawa Timur.

Waruwu, M. (2023). Pendekatan Penelitian Pendidikan: Metode Penelitian Kualitatif, Metode Penelitian Kuantitatif dan Metode Penelitian Kombinasi (Mixed Method). Jurnal Pendidikan Tambusai, 7(1), 2896-2910.

Dewi, D. A. I. P., Lely, A. A. O., & Aryastuti, S. A. (2023). Picturean Faktor Risiko Penyakit Demam Berdarah Dengue pada Anak di Wilayah Kerja Puskesmas Tabanan I. AMJ (Aesculapius Medical Journal), 3(1), 25-31.

WHO. (2011). Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Haemorrhagic Fever. In WHO Regional Publication SEARO (Issue 1)

Sholihah, S. H., Retnowati, E., & Fitria, N. E. L. (2023, January). Rasionalitas Penggunaan Parasetamol Pasien Anak 1-12 Tahun Dengue Hemorrhagic Fever di Instalasi Rawat Inap RS. In Prosiding University Research Colloquium (pp. 1571-1576).

Ningrum, D. M., & Permana, D. A. A. S. (2023). Kajian Pengobatan Dengue Haemoragic Fever (DHF) di Rumah Sakit Pendidikan Universitas Mataram. Lumbung Farmasi: Jurnal Ilmu Kefarmasian, 4(1), 1-6.

Meriska, N., Susanti, R., & Nurmainah, N. (2021). Evaluasi Penatalaksanaan Terapi Penyakit Demam Berdarah Dengue (Dbd) Pada Pasien Anak Di Instalasi Rawat Inap Rsud Sultan Syarif Mohamad Alkadrie Tahun 2019. Jurnal Mahasiswa Farmasi Fakultas Kedokteran UNTAN, 5(1).

Aliyyu, H. (2023). Picturean Kasus Demam Berdarah Dengue Pada Usia Anak Sekolah di RSUD Dr. Drajat Prawiranegara Tahun. Jurnal Locus Penelitian dan Pengabdian, 2(10), 978-986.